Literature DB >> 12870565

Effects of gabapentin on anxiety induced by simulated public speaking.

Fernanda de-Paris1, Marcia K Sant'Anna, Monica R M Vianna, Tatiana Barichello, Joao V Busnello, Flavio Kapczinski, Joao Quevedo, Ivan Izquierdo.   

Abstract

The effects of gabapentin, 400 mg and 800 mg, on anxiety induced by simulated public speaking (SPS) were investigated. Thirty-two normal male volunteers (aged 17-30 years) had their anxiety and mood evaluated by self-scales [Visual Analogue Mood Scale (VAMS) and Profile of Mood State (POMS)] during the SPS procedure. Physiological measures (heart rate and blood pressure) were taken. Treatment with gabapentin at 800 mg attenuated the anxiety of subjects that had a decrease on the VAMS item calm-excite. In addition, volunteers that received gabapentin at 400 mg and 800 mg showed a decrease in the hostility score in POMS. Our results suggest, in agreement with other studies, an anxiolytic potential to gabapentin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870565     DOI: 10.1177/0269881103017002006

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.

Authors:  Joshua A Lile; Michael J Wesley; Thomas H Kelly; Lon R Hays
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

Review 2.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

3.  Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.

Authors:  James J Prisciandaro; William Mellick; Lindsay M Squeglia; Sara Hix; Lauren Arnold; Bryan K Tolliver
Journal:  Addict Biol       Date:  2021-08-14       Impact factor: 4.093

Review 4.  Pharmacological challenge studies with acute psychosocial stress.

Authors:  Kathryne Van Hedger; Anya K Bershad; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2017-08-22       Impact factor: 4.905

5.  Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?

Authors:  Emin Onder; Umit Tural; Mehmet Gökbakan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

6.  Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery.

Authors:  Christophe Ménigaux; Frédéric Adam; Bruno Guignard; Daniel I Sessler; Marcel Chauvin
Journal:  Anesth Analg       Date:  2005-05       Impact factor: 6.627

7.  Comparative Study of Oral Gabapentin, Pregabalin, and Clonidine as Premedication for Anxiolysis, Sedation, and Attenuation of Pressor Response to Endotracheal Intubation.

Authors:  Chandrakant Waikar; Jaideep Singh; Deepesh Gupta; Aditya Agrawal
Journal:  Anesth Essays Res       Date:  2017 Jul-Sep

8.  Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.

Authors:  Antonio W Zuardi; Natália P Rodrigues; Angélica L Silva; Sandra A Bernardo; Jaime E C Hallak; Francisco S Guimarães; José A S Crippa
Journal:  Front Pharmacol       Date:  2017-05-11       Impact factor: 5.810

Review 9.  Threat Response System: Parallel Brain Processes in Pain vis-à-vis Fear and Anxiety.

Authors:  Igor Elman; David Borsook
Journal:  Front Psychiatry       Date:  2018-02-20       Impact factor: 4.157

10.  Effect of melatonin and gabapentin on anxiety and pain associated with retrobulbar eye block for cataract surgery: a randomized double-blind study.

Authors:  Marzieh-Beigom Khezri; Mohammad-Reza Oladi; Ali Atlasbaf
Journal:  Indian J Pharmacol       Date:  2013 Nov-Dec       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.